- Legal
Medical Record Review for Mass Torts: The Cohort Chronology Problem and How to Solve It?
A chronology built for one case is a document. A chronology built for a cohort has to be a dataset. Most mass tort record review produces the first thing and then needs the second.
Table of Contents
The short version
- Over 340,000 cases sat across 157 active federal MDLs as of December 2025, a majority of the federal civil docket.
- The questions that matter in an MDL are asked across the cohort, not within one file.
- PFS deficiency cascades run on fixed day counts, and they run against both sides.
- Rule 16.1, effective December 1, 2025, pushes the factual basis for each claim earlier.
Why the cohort is the unit of analysis?
In single-plaintiff litigation, a medical chronology is read closely by a handful of people, and depth is what makes it valuable. Narrative works. Nuance survives. The document is the deliverable.
In a mass tort, almost every operative question is asked across the whole inventory at once:
- Which claimants actually meet the case definition, on the diagnosis and exposure criteria as pleaded?
- Which have documented product identification, and from what source?
- Whose treatment timeline survives the applicable limitations period, and in which jurisdiction?
- Which files can answer the fact sheet completely today, and which are missing a specific record type?
- Which cases are plausible bellwether candidates on injury severity and record quality?
- How do claimants sort into settlement tiers when a matrix arrives?
None of those are answered by reading a chronology. They are answered by querying a set. That requires the same fields, captured the same way, with the same date conventions and the same injury coding, in every file. A firm holding four thousand well-written narrative chronologies cannot answer any question on that list without opening four thousand documents.
This is the cohort chronology problem. It is not a quality problem. Single-case methods applied at cohort scale produce work that is individually competent and collectively unusable.
The PFS cascade runs on fixed day counts
A Plaintiff Fact Sheet is case-specific discovery imposed by pretrial order rather than by the Federal Rules, so its content and timing vary by MDL. What is consistent is the structure: a completed and verified fact sheet, signed and dated authorizations, and all responsive documents, followed by a deficiency and cure sequence with dismissal at the end of it.
The Taxotere MDL is a useful reference because the sequence is set out explicitly in Amended Pretrial Order 22.
| Step | Window |
|---|---|
| Serve complete and verified PFS, signed authorizations, and all responsive documents | Within 75 days of filing the complaint |
| Defendants serve notice of deficiency via the MDL’s document platform | Within 45 days of PFS service |
| Plaintiff cures the deficiency | 30 days |
| Still-deficient cases added to the next status conference agenda | No briefing required |
| Order to show cause why the case should not be dismissed with prejudice | Returnable at the following status conference |
PFS sequence under Amended PTO 22, In re Taxotere (Docetaxel) Prods. Liab. Litig., MDL No. 16-2740 (E.D. La.). Other MDLs differ; check the governing order.
Deadlines elsewhere are tighter or looser but similar in shape. The Fluoroquinolone MDL required a completed and executed fact sheet within 60 days of a case joining the proceeding. In the Paragard IUD MDL, plaintiffs were required to cure deficiencies within 15 days of a deficiency notice, and those who did not were given 14 days to explain why their cases should not be dismissed with prejudice.
Two features of these orders matter operationally. The obligation is conjunctive, so a fact sheet served without authorizations or without responsive documents is deficient rather than partially complete. And the cure windows are short enough that curing requires records the firm already holds, organized well enough to locate the answer.
What deficiency looks like at scale?
Dismissals in this posture arrive in batches, not one at a time.
| MDL | Court | Action |
|---|---|---|
| Hair relaxer | N.D. Ill. (Rowland, J.) | 112 cases dismissed without prejudice for failure to submit a fact sheet and/or authorizations or respond to a deficiency letter; refiling permitted only within the MDL, with a complete PFS and authorizations within 10 business days |
| Paragard IUD | N.D. Ga. (May, J.) | 82 plaintiffs ordered to show cause within 14 days why their actions should not be dismissed with prejudice for uncured PFS deficiencies |
| Bair Hugger | D. Minn. (Ericksen, J.) | Defendant moved to dismiss 147 cases for deficient fact sheets |
| Taxotere | E.D. La. | Repeated show cause orders covering plaintiffs listed across six exhibits, with dismissals following non-compliance |
Examples of batch dismissal and show-cause practice in MDL fact sheet enforcement. Counts as reported in the orders and contemporaneous trade coverage.
The appellate posture is not favorable once a case reaches that point. In In re Taxotere (Kuykendall v. Accord Healthcare), 966 F.3d 351 (5th Cir. 2020), a plaintiff missed the original fact sheet deadline, an extended deadline, and a further thirty days granted to cure deficiencies. The Fifth Circuit affirmed dismissal with prejudice, applying a two-factor test drawn from its earlier MDL cases: whether there is a clear record of delay or contumacious conduct, and whether lesser sanctions would suffice. The court emphasized deference to the district court’s management of the proceeding. Later that year it affirmed dismissal with prejudice of four more Taxotere plaintiffs on the same basis.
The standard is worth reading carefully from the plaintiff side. It does not ask whether the records existed. It asks whether the record of delay is clear, which is a question answered by the docket rather than by the file.
A deficiency notice is not a request for more information. It is the opening of a fixed window, after which the remedy shifts from curing the file to explaining to a judge why the case should survive.
The clock runs against defendants too
Defense-side readers should note that the same orders bind them. In the Bair Hugger MDL, plaintiffs opposed a motion to dismiss 147 cases by arguing that in 145 of them the defendant had not served a deficiency notice within four weeks of receiving the fact sheet and had never sought an extension of time, waiving the objection.
That is the mirror image of the plaintiff-side problem. Reviewing several thousand incoming fact sheets against the underlying records, within a window measured in weeks per submission, is the same throughput exercise from the other direction. It also requires the same thing: consistent extraction, so that a reviewer can tell in minutes whether a claimed diagnosis, exposure window, or provider list is supported by the records produced.
Lone Pine orders spell out the specification for you
The fact sheet is not the only mechanism that asks whether a claim has a medical basis. Lone Pine orders, named for Lore v. Lone Pine Corp. (N.J. Super. Ct. Monmouth County, Nov. 18, 1986), require each claimant to produce prima facie evidence of injury, exposure, and causation by a date certain or face dismissal. In Lone Pine itself the court found the plaintiffs’ documentation so inadequate as to be unbelievable and dismissed with prejudice.
There is no direct authority for these orders in the Federal Rules, but they are generally accepted under a court’s case management powers, specifically Rule 16(c)(2)(L), which permits adoption of special procedures for managing protracted actions involving complex issues, multiple parties, or unusual proof problems. The Fifth Circuit approved the device in Acuna v. Brown & Root Inc., 200 F.3d 335, 340 (5th Cir. 2000).
What makes them relevant here is that a Lone Pine order states, in operative terms, exactly what the record set has to be able to produce. Pretrial Order No. 121 in the Avandia MDL required, for every plaintiff, a signed physician certification containing:
- A determination that the plaintiff used the product, with a list of the records documenting usage and the dates of usage;
- A determination that the plaintiff suffered one of the specified injuries within a defined period of use, or suffered it later together with a causation determination;
- Identification of the injury alleged, and the records documenting it;
- Copies of the records supporting the usage and injury determinations.
Read that as a field list rather than as a pleading requirement. Product identification with source records. Injury with date and source records. Causation. Copies attached. A firm that has already extracted its inventory to those fields answers a Lone Pine order by running a query. A firm that has not answers it by reopening every file under a deadline.
Two caveats worth stating. Lone Pine orders are discretionary and inconsistently applied, and scholarship has criticized them on exactly that ground, with Professor Nora Freeman Engstrom’s study in the Yale Law Journal arguing among other things that fact sheets can achieve many of the same aims at lower cost. And courts do refuse them: in the FEMA Trailer Formaldehyde MDL the court declined to enter one as premature.
That refusal is instructive for a different reason. The defendants there argued the burden would be slight because once the Plaintiffs’ Steering Committee had built a searchable database of the fact sheet data, the parties would have a clear idea of which plaintiffs had treated with a physician for a related illness and which had not. That argument was made in 2011. The premise, that the cohort becomes assessable once the underlying data is structured and queryable, is the same one this article is about.
Rule 16.1 moves the factual basis earlier
Federal Rule of Civil Procedure 16.1 took effect on December 1, 2025, the first Federal Rule written specifically for multidistrict litigation. It followed several years of study by an Advisory Committee subcommittee formed in 2017, prompted by the scale of MDL practice. Estimates of that scale vary with the measure: commentators put MDL cases at more than half of pending federal civil cases, and some at over 70% of the total federal caseload
The rule encourages the transferee court to schedule an initial management conference and, at the court’s direction, requires the parties to meet and report on leadership structure, consolidated pleadings, discovery, and early motion practice. For record review, the operative provision sits in the additional required content of that report at Rule 16.1(b)(3), which directs the parties to address how and when they will exchange information about the factual bases for their claims and defenses. The Advisory Committee Note connects that to a specific concern: that MDL proceedings may permit claims to be asserted without the inquiry Rule 11(b) calls for. Commentators have noted this is the only place in the rule that addresses meritless claims directly, and that most of the surrounding topics are hedged with “whether” or “likely” rather than stated as obligations.
The rule is permissive. It uses “should” and “in the court’s discretion” throughout, and the Committee Notes describe it as guidance rather than mandate, so how much it changes depends on individual judges. The direction of travel is clear enough regardless. In a personal injury mass tort, the factual basis for a claim is the medical record, and the expectation is that it exists earlier in the case than it often has.
What a cohort chronology has to contain?
The fix is not better prose. It is treating extraction as a schema problem, where every file yields the same structured fields and the narrative sits alongside them rather than instead of them.
| Field | Question it answers | What breaks it |
|---|---|---|
| Normalized diagnosis with date of first documentation and source page | Does this claimant meet the case definition, and when did the clock start? | Free-text injury descriptions that vary by reviewer |
| Product identification, with source type recorded (pharmacy record, chart note, claimant statement) | Which files have documentary product ID rather than recollection? | Recording the fact without recording its provenance |
| Exposure or use window, start and end, with confidence noted | Does the timeline fit the pleaded theory and the limitations period? | Single-date entries where a range is what exists |
| Provider inventory with dates of service and records-received status | Which providers are still outstanding, and is the fact sheet answerable today? | Listing providers without tracking what has actually arrived |
| Alternative cause and comorbidity flags, coded consistently | Which files carry the exposures the defense will raise? | Burying them in narrative where they cannot be counted |
| Injury severity indicators tied to defined criteria | How does this claimant sort when a settlement matrix arrives? | Severity assessed case by case against no fixed rubric |
| Record gaps recorded as gaps, with the interval stated | Which files are thin, before a deficiency notice says so? | Silent omission, which reads as complete |
| Whether a physician certification could be supported today, and by which records | Could this file answer a Lone Pine order? | Treating certification as a later problem |
| Every field traceable to a source page in the produced set | Can this be verified, cited, and defended? | Summaries that cannot be tied back to a document |
Fields that make a record set queryable across a cohort, and the question each one answers.
The test is simple. If a matrix lands tomorrow with four tiers defined by diagnosis, exposure duration, and severity, can the firm sort the inventory in an afternoon? If the answer requires reopening files, the record review produced documents rather than a dataset.
For settlement administrators reviewing cohort packages
The same inconsistency surfaces at the other end. A claim package assembled to a firm’s internal conventions has to be assessed against allocation criteria written by someone else, and variation between firms in how a diagnosis date or an exposure window was recorded becomes a source of disputed determinations and rework.
Packages that state each criterion explicitly, with a source page reference for each, resolve faster because the assessment is verification rather than reconstruction. That is the same property the fact sheet cascade rewards, applied at a different stage.
Why this is a volume problem before it is anything else?
A mass tort inventory of several thousand claimants, each with records from multiple providers across years, generates a document population that no amount of individual diligence can make consistent. Consistency is a function of the extraction standard, not of reviewer effort, and a standard only holds if it is applied the same way at page one and page four hundred thousand.
Rapid Care MRR’s record review platform was built for that shape of work: structured extraction to a defined field set across large claimant populations, source page references retained for every entry, gaps surfaced as gaps, and output that can be queried across the cohort rather than read one file at a time. Our overview of medical record review covers the underlying method.
The fact sheet deadline is not really a writing deadline. It is a question about whether the firm can find, in the records it already holds, the answer to a specific question about a specific claimant, several thousand times, in fifteen days.
Send us a sample of twenty files from an active inventory. We will return them extracted to a defined field set, with source page references retained and gaps flagged, so you can see what querying the cohort looks like before committing an inventory to it. Request a sample review. Files are handled under our HIPAA compliance program and returned or destroyed on request.
Frequently Asked Questions
What is a Plaintiff Fact Sheet in an MDL?
Case-specific discovery imposed by pretrial order rather than by the Federal Rules, so content and deadlines vary by MDL. It typically requires personal and medical history, product identification and use, alleged injury and diagnosis dates, treating providers, and other litigation history. Most orders require three things together: a completed and verified fact sheet, signed and dated authorizations, and all responsive documents requested in the fact sheet. Serving the questionnaire without the authorizations or documents is generally treated as deficient rather than partial.
What happens if a Plaintiff Fact Sheet is deficient?
Most pretrial orders establish a cascade: a deficiency notice within a set window after service, a defined cure period, listing at a status conference, then an order to show cause why the case should not be dismissed. Under Amended Pretrial Order 22 in the Taxotere MDL, that was notice within 45 days, a 30-day cure, listing at the next status conference with no briefing required, and a show cause order returnable at the following conference. In In re Taxotere (Kuykendall v. Accord Healthcare), 966 F.3d 351 (5th Cir. 2020), the Fifth Circuit affirmed dismissal with prejudice where a plaintiff failed to produce a complete fact sheet through several extensions, applying a two-factor test asking whether there is a clear record of delay or contumacious conduct and whether lesser sanctions would suffice.
Do defendants face deadlines in the PFS deficiency process?
Yes, and missing them can waive the objection. In the Bair Hugger MDL, plaintiffs opposed a motion to dismiss 147 cases by arguing that in 145 of them the defendant had not served a deficiency notice within four weeks of receiving the fact sheet and had never sought an extension. The mechanism runs in both directions.
How is medical record review different in a mass tort than in a single-plaintiff case?
The unit of analysis changes. In a single case, depth matters more than structure and the chronology is a narrative read once. In a mass tort, the questions are asked across the cohort: who meets the case definition, who has documented product identification, whose timeline survives the limitations period, which cases are bellwether candidates, how claimants sort into settlement tiers. Those are answered by querying a set, which requires the same fields captured the same way in every file.
How does Federal Rule of Civil Procedure 16.1 affect mass tort record review?
Rule 16.1 took effect December 1, 2025 as the first Federal Rule written specifically for MDL proceedings. It directs the parties to address how and when they will exchange information about the factual bases for their claims and defenses, and the Advisory Committee Note ties that to the concern that MDL claims have sometimes been asserted without the inquiry Rule 11(b) requires. The rule is permissive rather than mandatory, so its effect depends on individual judges, but the expectation it reflects is that the factual basis exists earlier. In a personal injury mass tort, that basis is the medical record.
How does Federal Rule of Civil Procedure 16.1 affect mass tort record review?
Rule 16.1 took effect December 1, 2025 as the first Federal Rule written specifically for MDL proceedings. It directs the parties to address how and when they will exchange information about the factual bases for their claims and defenses, and the Advisory Committee Note ties that to the concern that MDL claims have sometimes been asserted without the inquiry Rule 11(b) requires. The rule is permissive rather than mandatory, so its effect depends on individual judges, but the expectation it reflects is that the factual basis exists earlier. In a personal injury mass tort, that basis is the medical record.
How many cases are pending in federal MDLs?
As of December 2025, more than 340,000 cases were consolidated across 157 active federal MDLs, and MDL proceedings account for more than half of all pending federal civil cases. That scale is why a procedural rule specific to MDL management was adopted after several years of study.
What is a Lone Pine order and how does it differ from a Plaintiff Fact Sheet?
A Lone Pine order requires each claimant to produce prima facie evidence of injury, exposure, and causation by a date certain or face dismissal. It takes its name from Lore v. Lone Pine Corp. (N.J. Super. Ct. 1986), where the court found the plaintiffs’ documentation inadequate and dismissed with prejudice. There is no direct authority for such orders in the Federal Rules, but they are generally accepted under Rule 16(c)(2)(L), which permits special procedures for managing protracted actions with unusual proof problems, and the Fifth Circuit approved the device in Acuna v. Brown & Root. A fact sheet is standardized case-specific discovery served on every plaintiff; a Lone Pine order is a discretionary evidentiary gate, often requiring a physician certification supported by identified records. Lone Pine orders are applied inconsistently and courts sometimes refuse them as premature.
General information for litigation professionals, not legal advice. Fact sheet requirements, deficiency procedures, and deadlines are set by the pretrial orders in each individual MDL and vary substantially. Always work from the governing order in your proceeding.
